NCT03568630View on ClinicalTrials.gov

Blood Markers of Early Pancreas Cancer

RecruitingOBSERVATIONAL
Enrollment

1,250

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Diabetes Mellitus, Type 2PreDiabetesPancreas CystChronic PancreatitisGenetic Predisposition to DiseaseInherited Disease
Trial Locations (1)

68198

RECRUITING

Unversity of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Virginia Mason Hospital/Medical Center

OTHER

collaborator

VA Nebraska Western Iowa Health Care System

FED

lead

University of Nebraska

OTHER